CHIRALRES
How to separate columnless chiral compounds under mild conditions
Project description
This project concerns a suitable process that aims to separate particles in the nanometer range, i.e. both molecules and proteins & antibodies.
This process already offers the possibility of separating enantiomers without using various stationary chiral phases that are very costly for the pharmaceutical industry.
This gentle technique would also work to separate protein and/or antibody mixtures without any risk of degradation.
Why does Conectus invest in this project?
Conectus' financial investment will make it possible to:
- determine the potential of this separation technique.
- identify what minimum particle size it would be possible to separate.
- identify which types of materials are best suited for this technique.
- set up a prototype that is compatible with the desired separation.
At the origin of the project:
Thomas Hermans, Director of the Laboratory for Complex Non-Equilibrium Systems at the Institute of Supramolecular Science and Engineering (ISIS - Unistra CNRS
Focus
Conectus is investing in this project: €343,760
Ready to be licensed